Navigation Links
Venture-backed firms could become eligible for federal SBIR grants

.S. Small Business Administration ditched a broader interpretation of the law and began requiring 51 percent ownership by "natural persons."

These biotech firms, which ordinarily require significant amounts of venture capital funding to determine early success or failure of products, have since sought to reverse the ruling.

With the support of the

Source:wistechnology.com By Chris Fleissner 09/11/06


Page: 1 2 3 4

Related biology technology :

1. Venture-backed companies drive job creation, even in tough times
2. Study affirms information technology-productivity link
3. Madison biotech NimbleGen files for IPO; one of states best-funded firms
4. Wisconsin firms pledge to support healthcare IT standards
5. Wisconsin firms to present at Cleantech venture capital event
6. Madison life-science firms agree to co-develop kidney product
7. Wisconsin firms wont rush to adopt Microsoft Vista
8. Wisconsin court affirms damages in Innogenetics, Abbott patent case
9. CellCura could start an invasion of stem cell firms
10. Wisconsin firms urged to pursue federal SBIR dollars
11. Chippewa Valley firms land more defense work
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Venture backed firms could become eligible for federal SBIR grants

Other Biology Technology:Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 2Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 3Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 4Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 4WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 6WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 7WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 8WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 9WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 10WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 11WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 12Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL 2Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL 3